Reposted by Hugo Diniz, MD 🇵🇹🇪🇺Cristina Popa @nephroseeker.medsky.social · 19/10/2025📅 Coming next week, October 23, 2025, at 5:00 PM (CEST) #Nephsky #Medsky ✨E-seminar: Interventional Nephrology- A Beginner’s Guide for Young Nephrologists 🎙️Presenting @drbarbateba.bsky.social 💬Moderator @hugodiniz.medsky.social 👉You can register here www.era-online.org/video-pages/...era-online.orgInterventional Nephrology: A Beginner’s Guide for Young Nephrologists | ERARegister for the YNP e-Seminar on Interventional Nephrology: A Beginner’s Guide for Young Nephrologists. 1136 13
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 07/06/2025Thank you so much for attending and sharing our session 🤩 Next time, come say hi 👋 010 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Yeah. Hopefully the group with HFrEF gets some benefit 🤞 040 4
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Electronic Communication Committee getting their diplomas of merit at the Presidential dinner from the President Prof. @rosertorra.bsky.social #ERA25 ☺️ 051 5
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Yes @lonniepyne.bsky.social was the presenter! Hopefully he might sneak in to give his thoughts on the matter #ERA25 110 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Also, the last author presented a new meta analysis with ACHIEVE and ALCHEMIST. Considering only studies with low risk of bias, still no evidence of positive effect @hswapnil.medsky.social 100 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025So, about that. @pepasolerr.bsky.social asked about stratification by LVEF/echo data. Looks like only a small % had echo at baseline, but during follow up most patients got one. The author said they are going to look into that #ERA25 121 2
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Sorry, the app might have bugged on me. Are you talking about the Spironolactone trial? This replies are under the sglt2i aki analysis 100 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Me neither, but the study was well designed to answer the question. Regarding HF, I don't think so, but they basically used all the Empagliflozin trials for the analysis 110 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Prof Anders made a case for the (im)balance between workload (hyperfiltration) and nephron mass as the key interaction DM is a risk factor - there are no diabetic HF or diabetic cerebral vascular disease. Most cases are probably multifactorial HTN ckd probably doesnt exist and most are genetic 121 2
Reposted by Hugo Diniz, MD 🇵🇹🇪🇺Jayana Devathasan @jyndvthsn.bsky.social · 06/06/2025Vlado Perkovic discussing Sibeprenlimab (APRIL binder) at Late Breaking Clinic Trials II at #era25. Great to see Oceanians (Aus/NZers) on stage! 181 8
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Wasn't aware of that, thanks! Dr. Walsh mentioned it is already accepted for publication in a major journal #ERA25 020 2
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025ACHIEVE trial - Spironolactone in Hemodialysis stopped early... due to futility 😢 I had some hopes for this one. #ERA25 22211 22
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025iSGLT2 effects on Acute Kidney Outcomes #ERA25 ✅ Clear protective effects for AKI ❌ No extra risk of AKI events during the acute eGFR dip 1173 17
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Sibeprenlimab in IgA Nephropathy #ERA25 * Data presented is the 9-month reduction in proteinuria 031 3
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 06/06/2025Visionary interim analysis! #ERA25 massive reduction in proteinuria after 1 year of treatment 150 5
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025Reduce the Workload, save your kidneys #ERA25 140 4
Reposted by Hugo Diniz, MD 🇵🇹🇪🇺Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 05/06/2025I agree. Clinically it doesn’t hurt to try a flozin if a patient with diabetes or HF is on an MRA and has hyperkalemia since flozins are clearly indicated in that patient population But don’t bank on them to fix the issue - it’s a small effect even if true! #ERA25 #NephSky 192 9
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025Prof. Anders starting with a banger Diabetic Kidney Disease and Hypertensive Kidney Disease don't exist! 😱 #ERA25 3131 13
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025Ah, yes. By the way they presented it looked significant. But, still a small decrease is much better than an increased risk 😁media.tenor.coma glass half full of blue liquid on a gray backgroundALT: a glass half full of blue liquid on a gray background 001 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025Yes, the lack of morphological and hemodynamic data about the AVGs was also puzzling #ERA25 000 0
Reposted by Hugo Diniz, MD 🇵🇹🇪🇺Alex Meraz @nephroguy.bsky.social · 05/06/2025@kevinyau.bsky.social GLP1 agonist master Jedi presenting at #ERA25. 💉GLP1 agonist reduce ED visits and hospitalizations!!! 📉Awesome methods. Best of the session: 💊DDP4 for comparison, IPTW, ICES data. Ticking all the right boxes (EPI nerd). 💊Only 40% on SGLT2i!!! We should flozinate more!!! 394 9
Reposted by Hugo Diniz, MD 🇵🇹🇪🇺Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 05/06/2025The first #ERA25 simultaneous pub CONFIDENCE trial of empagliflozin + finerenone in N = 579 Greater reduction in ACR and BP Note the impressive GFR dip www.nejm.org/doi/full/10.... 34123 41
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025They are lower, both investigator-reported and K+ > 5.5 right? 120 2
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025Yes! Thank you. Probably too cautious #ERA25 P.S. Love your handle 010 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025#CONFIDENCE Simultaneous publication in @nejm.org www.nejm.org/doi/full/10.... 153 5
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025#CONFIDENCE Finerenone + Empagliflozin 52% drop in UACR at 180 days; More patients achieve the therapeutic targets Combination with less HiperK+! #ERA25 150 5
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 05/06/2025Its Starting! Are you #Confident? #ERA25 110 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 04/06/2025Great game by Vitinha and Conceição! 🇵🇹 2 x 1 🇩🇪 and into the final! Nice excuse to enjoy some beer with friends at #ERA25 🍻 000 0
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 04/06/2025Starting of #ERA25 by teaching some tips and tricks about kidney biopsies! Photo courtesy of @franvalga.bsky.social 120 2
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 04/06/2025And tomorrow, the Sun will shine even brighter! #ERA25 010 1
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 03/06/2025The official hashtag is #ERA25 🙌 #BeyondNephrology 010 1
Reposted by Hugo Diniz, MD 🇵🇹🇪🇺josh farkas 💊 @pulmcrit.bsky.social · 03/06/2025amiloride is such a great drug if someone diuresed with furosemide +/- thiazide suddenly dumps 3 liters of urine, their potassium goes to 2.5 with amiloride on board, the potassium just stays stable. someone needs to do an RCT proving that amiloride avoids dangerous hypokalemia 🙏 1114 11
Hugo Diniz, MD 🇵🇹🇪🇺 @hugodiniz.medsky.social · 03/06/2025So, who's going to Vienna for #ERA25? 🇦🇹 Seems like a nice event to transition to BlueSky! Thank you to everyone that followed me back! 231 3